On Friday 10 July, the European Parliament adopted (by 415 votes for to 252 against, with 20 abstentions) the proposal to object to a draft European Commission implementing act to extend the approval period for 26 active substances, including flumioxazine, a substance that has been identified as toxic for reproduction.
With this vote, MEPs are calling on the Commission to withdraw its draft implementing act and submit a new draft “that takes into account the scientific evidence on the...